{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:44Z","timestamp":1786984964443,"version":"build-2736575974"},"reference-count":153,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Norwegian PSC Research Center"},{"name":"South-Eastern Norway Regional Healthy Authority","award":["2015024"],"award-info":[{"award-number":["2015024"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbadis.2017.08.020","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T06:46:23Z","timestamp":1503643583000},"page":"1390-1400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"PB","title":["Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma"],"prefix":"10.1016","volume":"1864","author":[{"given":"Brian K.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Hemming","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.08.020_bb0005","first-page":"1","article-title":"Patient Age, Sex, and Inflammatory Bowel Disease Phenotype","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0010","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0020","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0050","first-page":"1","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","author":"Ji","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0065","doi-asserted-by":"crossref","unstructured":"European Society of Gastrointestinal Endoscopy, European Association for the Study of the Liver. European Association for the Study of the Liver, Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline, J. Hepatol. 66 (2017) 1265\u20131281. (Electronic address:) easloffice@easloffice.eu, doi:http:\/\/dx.doi.org\/10.1016\/j.jhep.2017.02.013.","DOI":"10.1016\/j.jhep.2017.02.013"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: Primary Sclerosing Cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.1840180311","article-title":"Establishment and immunological characterization of cultured human gallbladder epithelial cells","volume":"18","author":"Auth","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hep.1840140324","article-title":"Mechanisms and regulation of bile secretion","volume":"14","author":"Nathanson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2015.06.018","article-title":"Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis","volume":"63","author":"Carpino","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0115","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.34.9.1245","article-title":"Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines","volume":"34","author":"Ayres","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0120","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The Cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0168-8278(98)80149-9","article-title":"Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro","volume":"29","author":"Cruickshank","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.33.3.387","article-title":"Biliary complications of cystic fibrosis","volume":"33","author":"O'Brien","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0145","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0150","doi-asserted-by":"crossref","unstructured":"M.-M. Garcia-Barcel\u00f3, M.-Y. Yeung, X.-P. Miao, C.S.-M. Tang, G. Cheng, G. Chen, et al., Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2, Hum. Mol. Genet. 19 (2010) 2917\u20132925. doi:http:\/\/dx.doi.org\/10.1093\/hmg\/ddq196.","DOI":"10.1093\/hmg\/ddq196"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0155","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","article-title":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride","volume":"49","author":"Park","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0170","series-title":"The Gut Microbial Profile in Patients with Primary Sclerosing Cholangitis is Distinct from Patients with Ulcerative Colitis without Biliary Disease and Healthy Controls, gut","author":"Kummen","year":"2016"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0175","series-title":"Genetics of Primary Sclerosing Cholangitis and Pathophysiological Implications","first-page":"1","author":"Jiang","year":"2017"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0180","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II","volume":"9","author":"Rossen","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0190","series-title":"The Gut-adherent Microbiota of PSC-IBD is Distinct to that of IBD, gut","author":"Quraishi","year":"2016"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0205","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2005.03.040","article-title":"Cholangiocarcinoma","volume":"128","author":"Lazaridis","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0210","doi-asserted-by":"crossref","first-page":"237ra66","DOI":"10.1126\/scitranslmed.3008618","article-title":"The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota","volume":"6","author":"Balmer","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0220","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2015.12.017","article-title":"Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1","volume":"64","author":"Jeffery","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0225","series-title":"Hepatology","first-page":"746","article-title":"Primary sclerosing cholangitis: summary of a workshop","author":"LaRusso","year":"2006"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0230","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0250","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC study group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0255","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0260","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0265","doi-asserted-by":"crossref","unstructured":"S.A. Ahrendt, H.A. Pitt, A. Nakeeb, A.S. Klein, K.D. Lillemoe, A.N. Kalloo, et al., Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis, J. Gastrointest. Surg. 3 (1999) 357\u201367\u2013 (discussion 367\u20138).","DOI":"10.1016\/S1091-255X(99)80051-1"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/gast.2001.20875","article-title":"Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes","volume":"120","author":"Jaiswal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0275","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0280","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0285","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510300522","article-title":"Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line","volume":"30","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01213311","article-title":"Primary sclerosing cholangitis in Japan\u2014analysis of 192 cases","volume":"32","author":"Takikawa","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14228","article-title":"A gp130\u2013Src\u2013YAP module links inflammation to epithelial regeneration","volume":"519","author":"Taniguchi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0300","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1572-0241.2007.01220.x","article-title":"Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis","volume":"102","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0305","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12072-011-9260-4","article-title":"Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature","volume":"5","author":"Singal","year":"2011","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0310","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","article-title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression","volume":"107","author":"Song","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0315","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.27687","article-title":"IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism","volume":"61","author":"Yamada","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","author":"Zhou","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0330","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"21","author":"Valle","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0335","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1172\/JCI73742","article-title":"Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation","volume":"124","author":"Li","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0340","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2796.2001.00775.x","article-title":"Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma","volume":"249","author":"Bergquist","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0168-8278(00)00034-9","article-title":"Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis","volume":"34","author":"Fleming","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0360","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0365","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/j.dld.2015.01.052","article-title":"JNK signaling activated by platelet-derived growth factor D (PDGF-D) stimulates secretion of vascular endothelial growth factor-C (VEGF-C) by cancer-associated fibroblasts to promote lymphangiogenesis and early metastatization in cholangiocarcinoma","volume":"47","author":"Cadamuro","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0370","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0375","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.humpath.2014.05.008","article-title":"Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similarto cholangiocarcinoma","volume":"45","author":"MD","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0380","doi-asserted-by":"crossref","first-page":"G31","DOI":"10.1152\/ajpgi.00536.2002","article-title":"Bile acids activate EGF receptor via a TGF-\u03b1-dependent mechanism in human cholangiocyte cell lines","volume":"285","author":"Werneburg","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0385","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jhep.2004.07.016","article-title":"Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells","volume":"41","author":"Yoon","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0390","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/gast.2002.32410","article-title":"Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOG.0000000000000336","article-title":"Immunogenetics in primary sclerosing cholangitis","volume":"33","author":"Chung","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125793","article-title":"Lipopolysaccharide (LPS)-induced biliary epithelial cell NRas activation requires epidermal growth factor receptor (EGFR)","volume":"10","author":"Trussoni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0405","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.28116","article-title":"High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires","volume":"63","author":"Liaskou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0410","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","author":"Chung","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0415","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","article-title":"Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells","volume":"128","author":"Kobayashi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0420","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2001.25513","article-title":"Identification of oxysterols in human bile and pigment gallstones","volume":"121","author":"Haigh","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0425","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2040622313478646","article-title":"Treatment of autoimmune liver disease: current and future therapeutic options","volume":"4","author":"Trivedi","year":"2013","journal-title":"Ther. Adv. Chronic Disord."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0430","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.20125","article-title":"Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis","volume":"39","author":"Yoon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0435","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/clp.12.53","article-title":"Mechanisms of oxysterol-induced disease: insights from the biliary system","volume":"7","author":"Kuver","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0440","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1074\/jbc.M611741200","article-title":"Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells","volume":"282","author":"Dwyer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0445","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nri3407","article-title":"Triggers and drivers of autoimmunity: lessons from coeliac disease","volume":"13","author":"Sollid","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0450","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hep.26147","article-title":"Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma","volume":"57","author":"El Khatib","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0455","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.freeradbiomed.2005.07.005","article-title":"Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage","volume":"39","author":"Komichi","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0460","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0470","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","article-title":"Contribution of MicroRNAs to autoimmune diseases","volume":"73","author":"Garo","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0475","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI81131","article-title":"Regulation of chronic inflammatory and immune processes by extracellular vesicles","volume":"126","author":"Robbins","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0480","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.12776","article-title":"Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"185","author":"Bernuzzi","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0485","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.dld.2012.12.017","article-title":"Digestive and liver disease","volume":"45","author":"Krawczyk","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0490","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.25890","article-title":"Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma","volume":"56","author":"Oishi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0495","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3892\/mmr.2013.1516","article-title":"cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide","volume":"8","author":"Yeh","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0500","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1568","article-title":"The role of BH3-only proteins in the immune system","volume":"5","author":"Strasser","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0505","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"Meng","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0510","doi-asserted-by":"crossref","first-page":"23058","DOI":"10.18632\/oncotarget.5492","article-title":"Regulation of Bim in Health and Disease","volume":"6","author":"Sionov","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0515","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2014.12.018","article-title":"Extracellular metabolic energetics can promote cancer progression","volume":"160","author":"Loo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0520","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5009\/gnl16033","article-title":"Biology of Cholangiocytes: from bench to bedside","volume":"10","author":"Yoo","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0525","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.21155","article-title":"CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction","volume":"117","author":"Contardi","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0530","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2007-1007153","article-title":"Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma","volume":"18","author":"Celli","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0535","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0540","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0545","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0550","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0555","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/jhep.2001.27543","article-title":"Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles","volume":"34","author":"Wiencke","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0560","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/carcin\/bgp118","article-title":"Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma","volume":"30","author":"Forsbring","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0565","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature21039","article-title":"Rare and low-frequency coding variants alter human adult height","volume":"542","author":"Marouli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0570","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.510310302","article-title":"Functional heterogeneity of the intrahepatic biliary epithelium","volume":"31","author":"Kanno","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0575","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-213X-11-56","article-title":"Three-dimensional reconstructions of intrahepatic bile duct tubulogenesis in human liver","volume":"11","author":"Vestentoft","year":"2011","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0580","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/dvdy.21530","article-title":"Cholangiocyte primary cilia in liver health and disease","volume":"237","author":"Masyuk","year":"2008","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0585","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2009.03.035","article-title":"Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies","volume":"137","author":"Lemaigre","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0590","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0595","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0600","first-page":"G767","article-title":"Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation","volume":"274","author":"Alpini","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0605","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.510290242","article-title":"Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver","volume":"29","author":"LeSage","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0610","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2011.09.022","article-title":"Development of the bile ducts: essentials for the clinical hepatologist","volume":"56","author":"Strazzabosco","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0615","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/icb.2008.37","article-title":"The immunobiology of cholangiocytes","volume":"86","author":"Chen","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0620","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.4049\/jimmunol.175.11.7447","article-title":"Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium Parvum via activation of NF-kappaB","volume":"175","author":"Chen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0625","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2006.01254.x","article-title":"Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0630","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ni1274","article-title":"Limiting inflammatory responses during activation of innate immunity","volume":"6","author":"Han","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0635","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0640","doi-asserted-by":"crossref","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212\/\u2212 mice","author":"Devkota","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0645","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0650","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0655","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0660","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0665","first-page":"98","article-title":"Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature","volume":"39","author":"McGarr","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0670","first-page":"298","article-title":"Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis","volume":"18","author":"Broome","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0675","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004280050077","article-title":"Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"431","author":"Dienes","year":"1997","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0680","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0685","first-page":"6500","article-title":"Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor\/Raf-1-dependent mechanism","volume":"62","author":"Yoon","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0690","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","article-title":"Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death","volume":"57","author":"Ichim","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0695","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.molcel.2015.03.003","article-title":"Caspase-3 promotes genetic instability and carcinogenesis","volume":"58","author":"Liu","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0700","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1276646","article-title":"Genetics of hepatobiliary carcinogenesis","volume":"31","author":"Nault","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0705","doi-asserted-by":"crossref","first-page":"G129","DOI":"10.1152\/ajpgi.00242.2005","article-title":"Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells","volume":"290","author":"Ishimura","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0710","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.0802702105","article-title":"Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease","volume":"105","author":"Takeda","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0715","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1038\/onc.2010.242","article-title":"TRAIL treatment provokes mutations in surviving cells","volume":"29","author":"Lovric","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0720","doi-asserted-by":"crossref","first-page":"29568","DOI":"10.1074\/jbc.M603307200","article-title":"Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence","volume":"281","author":"Copp\u00e9","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0725","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.211053698","article-title":"Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging","volume":"98","author":"Krtolica","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0730","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0735","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3275","article-title":"Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation","volume":"33","author":"Sampaziotis","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0740","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0745","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/1097-0142(19920715)70:2<410::AID-CNCR2820700207>3.0.CO;2-R","article-title":"The WHO Histological Classification of Tumors of the Gallbladder and Extrahepatic Bile Ducts. A commentary on the second edition","volume":"70","author":"Albores-Saavedra","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2017.08.020_bb0750","first-page":"11","article-title":"Accuracy and morphologic aspects of pancreatic and biliary duct brushings","volume":"39","author":"Layfield","year":"1995","journal-title":"Acta Cytol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb0755","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb5000","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.020_bb5005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/00365521.2012.682090","article-title":"Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis","volume":"47","author":"Srivastava","year":"2012","journal-title":"Scand. J. Gastroenterol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:42:05Z","timestamp":1760416925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917303022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0925443917303022"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.020","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}